[1]
G. M. de Oliveira, E. T. M. F. S. Vasconcelos, M. L. F. C. Rocha, F. de M. Cunha, H. A. M. Segundo, and F. B. Duarte, “Real-world outcomes of BCL2 inhibitor-based combination therapy in myelodysplastic syndrome and acute myeloid leukemia – Experience from a university hospital in northeastern Brazil”, J Bone Marrow Transplant Cell , vol. 7, no. 1, Mar. 2026.